ATRA vs ESS · rev $128.9M vs P/E 31, rev $1.89B
Atara Biotherapeutics Inc (ATRA) versus Essex Property Trust Inc (ESS) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Essex Property Trust Inc (ESS) is a reit - residential company listed on NYSE.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported ESS revenue for 2025-12-31 was $1.89B. Net income was $702.8M. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
ATRA currently screens at market cap $87.1M. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
Not investment advice. Open the ATRA and ESS stock pages for the full models.
Not investment advice.